Data broker RELX is represented on Twitter by their Chief Communications Officer Paul Abrahams. Due to RELX subsidiary Elsevier being one of the largest publishers of academic journals, Dr. Abrahams frequently engages with academics on the social media platform. On […] ↓ Read the rest of this entry…
Or let’s think a a few sizes smaller and imagine a renowned pulmonologist taking the, say, “Marlboro Endowed Chair” in the Mayo Clinic’s Pulmonary Medicine Division, sponsored by Philip Morris. What would they have to endure and how much credibility […] ↓ Read the rest of this entry…
The market power of academic publishers has been a concern for all those academic fields where publication in scholarly journals is the norm. For most non-economist researchers, the anti-trust aspects of academic publishing are likely confusing and opaque. For instance, […] ↓ Read the rest of this entry…
According to a recent study, employee surveillance is rampant in today’s corporate work environment. This study documents how, often under the pretense of cybersecurity or risk analysis (sort of like academic publishers, actually), companies analyze the behavioral data they collect […] ↓ Read the rest of this entry…
There has been some outrage at the announcement that Nature is following through with their 2004 declaration of charging ~10k ($/€) in article processing charges (APCs). However, not only have these charges been 16 years in the making but the […] ↓ Read the rest of this entry…
Last week, there was a lot of outrage at the announcement of Nature’s new pricing options for their open access articles. People took to twitter to voice their, ahem, concern. Some examples: There are many more that all express their […] ↓ Read the rest of this entry…
Just before Christmas 2019, the Washington Post reported, based on “people familiar with the matter”, that the US Justice Department were investigating the Sci-Hub founder Alexandra Elbakyan for potentially “working with Russian intelligence to steal U.S. military secrets from defense […] ↓ Read the rest of this entry…
The New England journal of Medicine has come out strongly against Open Access. Apparently, this journal does not seem to value access to medical information very highly. This lack of valuation could be due to several reasons. For one, the […] ↓ Read the rest of this entry…
Time and time again, academic publishers have managed to create the impression that publishing incurs a lot of costs which justify the outrageous prices they charge, be that US$11M p.a. for an Elsevier Big Deal subscription or an article processing […] ↓ Read the rest of this entry…
Notwithstanding the barrage of criticisms and warnings from every corner of the scholarly community, various initiatives, mainly in the Netherlands, Finland, Germany, France and the UK, continue their efforts for a smooth transition from subscriptions to open access without any […] ↓ Read the rest of this entry…
bjoern.brembs.blog by Björn Brembs is licensed under a Creative Commons Attribution 3.0 Unported License.
theme modified from Easel